At the end of the first 3 years
Testimony and new challenges
Getting to grips with complexity of disease will make genomics useful in arterial thrombosis
No praise for folly
Fibrinogen and factor VIIc levels
Long-term effects of hemostatic variables on fatal coronary heart disease
Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin
Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism
The incidence of venous thromboembolism following gynecologic laparoscopy
Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection
The humoral response to human factor VIII in hemophilia A mice
Microparticle-associated tissue factor activity
Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay
A major role for Scar/WAVE-1 downstream of GPVI in platelets
α IIb β3 priming and clustering by orally active and intravenous integrin antagonists
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome
Persistence of procoagulant surface expression on activated human platelets
Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin
Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or β3 integrin
Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis
Generation of soluble P- and E-selectins in vivo is dependent on expression of P-selectin glycoprotein ligand-1
The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis
HIV and hemophilia
HIV and hemophilia
HIV and hemophilia
Depletion of CD4+/CD25high regulatory T cells may enhance or uncover factor VIII-specific T-cell responses in healthy individuals
Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis
Detecting antithrombin deficiency may be a difficult task – more than one test is necessary
Haplotypes encoding the factor VIII 1241Glu variation and the risk of myocardial infarction
Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia
High levels of LDL-cholesterol rescue the neonatal mortality associated with afibrinogenemia in mice
Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q
Idiopathic subclavian vein thrombosis
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
Thrombotic thrombocytopenic purpura
Clinical sample investigation (CSI) hematology
Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes
Quantitative real-time reverse transcription polymerase chain reaction analysis of a novel tissue factor splice variant in select human solid tumors
Thrombosis in paroxysmal nocturnal hemoglobinuria
The parachute must be properly folded …
Interesting variations on how a disease is defined
Interesting variations on how a disease is defined
My remembrance of Tage Astrup (1908–2006)